Wolfgang Miesbach: How SUMOylation Limits AAV Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
”Gene therapy: same vector, same dose — up to 20 times more transgene.
Vector delivers the gene — the hepatocyte determines how efficiently it works.
At ISTH 2026, Denise Sabatino presented data identifying SUMOylation — a common host post-translational modification — as a restriction factor for transgene expression in AAV-transduced cells.
The agent: TAK-981 (subasumstat), a clinical-stage SUMO-activating enzyme inhibitor.
- In vitro: up to approximately 20 times higher transgene expression, across all cell types and promoters tested
- In vivo: around 36 times, 90 times and 200 times luciferase at days 1, 2 and 3
- Vector copy number lower while transgene mRNA and protein higher — driven not by increased vector uptake but by de-repression within the transduced cell
- Therapeutic transgenes: around 4 times FVIII (haemophilia A) and ~2× FIX-Padua (haemophilia B), including dosing months after transduction
- Effect transient and repeatable — a pharmacologically tunable intervention
SUMO-mediated restriction is an underappreciated limitation of AAV gene therapy, independent of serotype, promoter and transgene.
Modulating it may improve the durability and efficacy of expression — a relevant target for a field focused on long-term, predictable transgene output.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI